| Thanks to SoCalBio Weekly Update Sponsor |
Coming in 2010 Benefiting Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| February 15, 2010  | |
 | |
| RSVP Now for Upcoming SoCalBio Events | 
SoCalBio Networking Forum
The Life-Science Industry in the Media:
Insights on How to Use the Media to Promote your Company and Technology
Date: February 25, 2010
Time: 4:00 pm - 7:00 pmLocation: Sierra Room, Wilshire Grand Hotel (downtown Los Angeles) RSVP:https://www.123signup.com/register?id=jyvbc************************************************
SoCalBio Executive Roundtable Discussion
Regenerative Medicine Luncheon and Discussion
(Open only to executives and managers in regenerative medicine companies)
Date: April 6, 2010 Time 11 - 2:00 Location: TBA By Invitation Only (for more info, contact SoCalBio at
scbc@socalbio.org or call 213-236-4890) *************************************************
SoCalBio HR Symposium
Best Practices in Designing Wellness Programs
Join us to learn how to craft wellness programs to improve employee health, reduce medical claims, and guarantee a return on investment
(Open only to HR professionals in medical device, IVD, biotech and generic pharma firms)
Date: April 15, 2010
Time: 9:00am - 1:30pm
Location: One Lambda Corp. (Canoga Park)
By Invitation Only (for more info, contact SoCalBio at
scbc@socalbio.org or call 213-236-4890) Join the SoCalBio HR Network on LinkedIn****************************** *******************
SoCalBio Regulatory Best Practice Workshop
The Shifting Paradigm in FDA Process Validation
This SoCalBio workshop focuses on the FDA's guidelines regarding Process Validation. It is designed for device and pharma regulatory affairs professionals to learn what is required to approach process validation from a life cycle perspective and incorporates modern risk management and quality systems tools and concepts. |
| Company Update | Viral Genetics' CEO Issues State of the Company Update
Headquartered in San Marino, Calif., Viral Genetics discovers and develops drug therapies to treat infectious, autoimmune, and immunological deficiency disorders using its thymus nuclear protein compound
(TNP). "During 2009, Viral Genetics made significant strides on two fronts -- scientific and financial. Our drug compounds seem to be showing great potential. Additionally, we've built an infrastructure that enables us to use money wisely. We have retired nearly all of our external debt, enabling us to leverage any additional funding to advance new drug therapies -- rather than making interest payments to creditors." said Haig Keledjian, Viral Genetics' CEO ... Read more |
| Clinical Studies | Reshape Medical (San Clemente)
Doctors at UCI Study Stomach Balloon for Weight Loss
 The device (graphic right) is scheduled to undergo its first U.S. clinical trial starting this spring among 30 patients at three medical centers, including UCI.. The startup's vice president of research and development, Mark Ashby, said the design -- a double-balloon mechanism that is inserted down the patient's throat with a tube attached and then inflated with saline -- is an improvement over its predecessors such as the
Garren-Edwards gastric bubble introduced in 1984 ... Read moreNew Data Show Superior Outcomes With Edwards Lifesciences' FloTrac System
The randomized, controlled clinical trial of 60 high-risk abdominal surgery patients found that enhanced hemodynamic monitoring with the FloTrac system reduced hospital stay by more than 20 percent when compared to standard monitoring (15.1 +/- 4.1 days versus 19.7 +/- 8.6 days) ... Read more |
|  |
| IP | AVANIR Pharmaceuticals Announces Issuance of New U.S. Zenvia Patent
The Aliso Viejo-based firm announced a new patent for its lead drug candidate Zenvia (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA). ... Read more |
New Product
| Clarient Launches New Lung Cancer Test
The Aliso Viejo-based firm announced the commercial launch of a new lung cancer test, Clarient Insight Dx Pulmotype Test, that helps physicians classify specific types of lung cancer to identify which therapies may be most effective. The new test has been clinically validated to use in the sub-classification of patients with non-small cell lung cancer (NSCLC), which accounts for approximately 85 percent of the more than 200,000 lung cancer cases diagnosed each year.... Read more |
Personnel
| Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer
 The Monrovia-based company using Fc engineering for the discovery and development of next-generation antibodies announced the appointment of Edgardo Baracchini, Ph.D. (photo right), to chief business officer. He brings more than 15 years of transactional experience to Xencor, most recently as senior vice president of business development at Metabasis Therapeutics until its merger with Ligand Pharmaceuticals in 2009 ... Read more |
| Jobs Available | 
Agensys (Santa Monica) Agensys is now part of Astellas Pharma
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
